DCF — CARLE EUREKA HOSPITAL
Enterprise Value: $-25.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-25.5M
Enterprise Value
$-8.4M
PV of Cash Flows
$-17.1M
PV of Terminal Value
$-27.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $25.5M | $-1.4M | -6.0% | $-2.5M | $-2.3M |
| Year 2 | $26.3M | $-1.2M | -5.0% | $-2.3M | $-1.9M |
| Year 3 | $27.1M | $-1.0M | -4.0% | $-2.1M | $-1.6M |
| Year 4 | $27.9M | $-0.8M | -3.0% | $-2.0M | $-1.4M |
| Year 5 | $28.7M | $-0.8M | -3.0% | $-2.0M | $-1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-25.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$24.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06025589719243259
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5